Quarterly report [Sections 13 or 15(d)]

Stock-based Compensation

v3.26.3
Stock-based Compensation
9 Months Ended
Sep. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Stock-based Compensation

Note 10 – Stock-based Compensation

 

2013 Plan

 

On August 2, 2013, the Company’s Board of Directors (the “Board”) adopted the 2013 Equity Compensation Plan (as amended to date, the “2013 Plan”) pursuant to the terms described herein. The 2013 Plan was approved by the stockholders on August 7, 2013. Effective May 8, 2014, upon the approval of the Company’s Board and its stockholders, the Company amended and restated the 2013 Plan, primarily to include “evergreen” provisions, which provided that the number of shares of common stock available for issuance under the 2013 Plan is subject to an automatic annual increase on January 1 of each year beginning in 2015; to amend the definition of “fair market value”; and to increase the limits on awards under the 2013 Plan. The 2013 Plan, which expired on May 7, 2024, provided for the granting of incentive stock options, non-qualified stock options, restricted stock units, performance units, and stock purchase rights.

 

 

As of September 30, 2026, there were 23,714 awards, including both restricted stock grants and option grants, issued and exercised under the 2013 Plan and no remaining shares available for grant under the 2013 Plan.

 

2025 Plan

 

On April 30, 2025, the Company’s Board, subject to the approval of its stockholders, which was received on June 23, 2025, adopted a new 2025 Equity Incentive Plan (the “2025 Plan”) to succeed the 2013 Plan. The general purpose of the 2025 Plan is to provide an incentive to its employees, directors, consultants and advisors by enabling them to share in the future growth of our business. The term of the 2025 Plan is 10 years. The 2025 Plan includes the “evergreen” provisions, which provides that the number of shares of common stock available for issuance under the 2025 Plan is subject to an automatic annual increase on January 1 of each year beginning in 2026. Therefore, an additional 17,083 shares were automatically made available for issuance on the first trading day of 2026, which represented 4.0% of the number of shares outstanding on December 31, 2025. As of the date of this filing, these shares have not been registered.

 

The maximum number of shares of common stock of the Company that are available for issuance under the 2025 Plan is 67,952 shares. As of September 30, 2026, there were 60,186 remaining shares available for grant under the 2025 Plan.

 

The Company recognized stock-based compensation expense for stock options in its condensed consolidated statements of operations as follows:

 

    2026     2025     2026     2025  
   

Three Months Ended September 30,

   

Nine Months Ended September 30,

 
    2026     2025     2026     2025  
Research and Development   $ —     $ —     $ —     $ 85  
General and Administrative     100       253       317       721  
Total   $ 100     $ 253     $ 317     $ 806  

 

Stock Options

 

The following table summarizes the activity for the Company’s stock options for the nine months ended September 30, 2026:

 

    Number of Shares     Weighted Average Exercise Price     Weighted Average Contractual Term (Years)     Aggregate Intrinsic Value (a)  
Outstanding at December 31, 2025     30,481     $  521.40       6.5     $ —  
Granted     —       —               —  
Exercised     —       —               —  
Forfeited     (850 )     234.15               —  
Expired     (4,668 )     690.15               —  
Outstanding at September 30, 2026     24,963      $ 499.65       6.04      $ —  
Exercisable at September 30, 2026     20,472      $ 593.40       5.58      $ —  

 

(a) The aggregate intrinsic value in the above table was calculated on the positive difference, if any, between the closing price per share of the Company’s common stock on September 30, 2026 of $2.33 and the split-adjusted per share exercise price of the underlying options.

 

As of September 30, 2026, unamortized stock-based compensation for stock options outstanding was $290 and is expected to be recognized over a weighted average period of 1.23 years. Total unrecognized compensation cost will be adjusted for future forfeitures, if necessary.